These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 12183275

  • 21. Bacteriological activity of trovafloxacin, a new quinolone, against respiratory tract pathogens.
    Pechère JC, Gootz TD.
    Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):405-12. PubMed ID: 9758283
    [Abstract] [Full Text] [Related]

  • 22. Comparative in vitro activities of trovafloxacin (CP-99,219) against 445 gram-positive isolates from patients with endocarditis and those with other bloodstream infections.
    Endtz HP, Mouton JW, den Hollander JG, van den Braak N, Verbrugh HA.
    Antimicrob Agents Chemother; 1997 May; 41(5):1146-9. PubMed ID: 9145886
    [Abstract] [Full Text] [Related]

  • 23. Antipneumococcal activities of gemifloxacin compared to those of nine other agents.
    Davies TA, Kelly LM, Pankuch GA, Credito KL, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 2000 Feb; 44(2):304-10. PubMed ID: 10639354
    [Abstract] [Full Text] [Related]

  • 24. In vitro and in vivo antibacterial activities of KB-5246, a new tetracyclic quinolone.
    Kotera Y, Mitsuhashi S.
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1896-900. PubMed ID: 2610501
    [Abstract] [Full Text] [Related]

  • 25. In vitro and in vivo antibacterial efficacies of CFC-222, a new fluoroquinolone.
    Kim JH, Kang JA, Kim YG, Kim JW, Lee JH, Choi EC, Kim BK.
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2209-13. PubMed ID: 9333049
    [Abstract] [Full Text] [Related]

  • 26. Comparative in-vitro activities of trovafloxacin, ciproflaxacin, ofloxacin, and broad-spectrum beta-lactams against aerobe blood culture isolates.
    Seifert H.
    Zentralbl Bakteriol; 1998 Dec; 288(4):509-18. PubMed ID: 9987189
    [Abstract] [Full Text] [Related]

  • 27. Bactericidal activity of gemifloxacin and other quinolones against Streptococcus pneumoniae.
    Morrissey I, George JT.
    J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():107-10. PubMed ID: 10824041
    [Abstract] [Full Text] [Related]

  • 28. The in-vitro activity of trovafloxacin, a new fluoroquinolone, against Gram-positive bacteria.
    Sefton AM, Maskell JP, Rafay AM, Whiley A, Williams JD.
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():57-62. PubMed ID: 9222071
    [Abstract] [Full Text] [Related]

  • 29. In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone.
    Hosaka M, Yasue T, Fukuda H, Tomizawa H, Aoyama H, Hirai K.
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2108-17. PubMed ID: 1332587
    [Abstract] [Full Text] [Related]

  • 30. In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.
    Fujimaki K, Noumi T, Saikawa I, Inoue M, Mitsuhashi S.
    Antimicrob Agents Chemother; 1988 Jun; 32(6):827-33. PubMed ID: 2843082
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of gemifloxacin (SB-265805, LB20304a): in vitro activity against over 6000 gram-positive pathogens from diverse geographic areas.
    Jones RN, Pfaller MA, Erwin ME.
    Int J Antimicrob Agents; 2000 Aug; 15(3):227-30. PubMed ID: 10926446
    [Abstract] [Full Text] [Related]

  • 32. [Antibacterial activity of tosufloxacin against fresh clinical isolates].
    Yamashiro Y, Shimakura M, Minami S, Fukuoka Y, Yasuda T, Watanabe Y, Narita H, Akama M.
    Jpn J Antibiot; 1994 Mar; 47(3):245-54. PubMed ID: 8182895
    [Abstract] [Full Text] [Related]

  • 33. Antibacterial activity of trovafloxacin against nosocomial Gram-positive and Gram-negative isolates.
    Cunha BA, Qadri SM, Ueno Y, Walters EA, Domenico P.
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():29-34. PubMed ID: 9222067
    [Abstract] [Full Text] [Related]

  • 34. Antibacterial properties of AM-1155, a new 8-methoxy quinolone.
    Hosaka M, Kinoshita S, Toyama A, Otsuki M, Nishino T.
    J Antimicrob Chemother; 1995 Aug; 36(2):293-301. PubMed ID: 8522459
    [Abstract] [Full Text] [Related]

  • 35. In-vitro activity of clinafloxacin, trovafloxacin, and ciprofloxacin.
    Cohen MA, Huband MD, Gage JW, Yoder SL, Roland GE, Gracheck SJ.
    J Antimicrob Chemother; 1997 Aug; 40(2):205-11. PubMed ID: 9301985
    [Abstract] [Full Text] [Related]

  • 36. Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus.
    Gootz TD, Zaniewski RP, Haskell SL, Kaczmarek FS, Maurice AE.
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1845-55. PubMed ID: 10428901
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. In vitro activity of gemifloxacin (SB-265805) compared to eleven other antimicrobial agents against streptococcal isolates, excluding Streptococcus pneumoniae.
    Kerawala M, Ambler JE, Lee PY, Drabu YJ.
    Eur J Clin Microbiol Infect Dis; 2001 Apr; 20(4):271-5. PubMed ID: 11399019
    [Abstract] [Full Text] [Related]

  • 39. In vitro activity of gemifloxacin against recent clinical isolates of bacteria in Korea.
    Yong DE, Cheong HJ, Kim YS, Park YJ, Kim WJ, Woo JH, Lee KW, Kang MW, Choo YS.
    J Korean Med Sci; 2002 Dec; 17(6):737-42. PubMed ID: 12482994
    [Abstract] [Full Text] [Related]

  • 40. In vitro susceptibility to gemifloxacin and trovafloxacin of Streptococcus pneumoniae strains exhibiting decreased susceptibility to ciprofloxacin.
    Fuentes F, Giménez MJ, Marco F, Alou L, Aguilar L, Prieto J.
    Eur J Clin Microbiol Infect Dis; 2000 Feb; 19(2):137-9. PubMed ID: 10746503
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.